Evidence map›Paper›PMID 32294412›Full record

ReviewStem cell reports2020

Chimeric Humanized Vasculature and Blood: The Intersection of Science and Ethics.

Daniel J Garry, Arthur L Caplan, Mary G Garry

Abstract readReview
In one paragraph

Review in Stem cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daniel J GarryLillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA; Stem Cell Institute, University of Minnesota, Minneapolis, MN 55455, USA; Regenerative Medicine and Sciences Program, Paul and Sheila Wellstone Muscular Dystrophy Center, University of Minnesota, 2231 6(th) Street SE (CCRB 4-146), Minneapolis, MN 55455, USA. Electronic address: garry@umn.edu.
Arthur L CaplanDivision of Medical Ethics, New York University Langone Medical Center, New York, NY 10016, USA.
Mary G GarryLillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA; Stem Cell Institute, University of Minnesota, Minneapolis, MN 55455, USA; Regenerative Medicine and Sciences Program, Paul and Sheila Wellstone Muscular Dystrophy Center, University of Minnesota, 2231 6(th) Street SE (CCRB 4-146), Minneapolis, MN 55455, USA.

Funding

Bioengineering Strategies for Cardiovascular DiseaseR01HL144582 · NHLBI · UNIVERSITY OF MINNESOTA · PI GARRY, DANIEL J. · 2019 to 2022
$3.1M
NHLBI NIH HHS R01 HL144582
6 · The paper itself

Abstract

The only curative therapy for diseases such as organ failure is orthotopic organ transplantation. Organ transplantation has been limited due to the shortage of donor organs. The huge disparity between those who need and those who receive transplantation therapy drives the pursuit of alternative treatments. Therefore, novel therapies are warranted. Recent studies support the feasibility of generating human-porcine chimeras that one day would provide humanized vasculature and blood for transplantation and serve as important research models. The ethical issues they raise require open discussion and dialog lest promising lines of inquiry flounder due to unfounded fears or compromised public trust.

Indexed as

Ethics, ResearchScienceAnimalsBloodBlood VesselsChimeraGenetic EngineeringHumanschimerascomplementationethicsEtv2humanpig

Identifiers

PMID32294412
PMCPMC7160389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.